Literature DB >> 29760130

Clinical, Radiological, and Microbiological Characteristics of Mycobacterium simiae Infection in 97 Patients.

Nathalie Coolen-Allou1, Thomas Touron2, Olivier Belmonte3, Virgile Gazaille2, Michel Andre2, Jérôme Allyn4, Sandrine Picot5, Annabelle Payet6, Nicolas Veziris7,8.   

Abstract

Mycobacterium simiae is a rare species of slow-growing nontuberculous mycobacteria (NTM). From 2002 to 2017, we conducted a retrospective study that included all patients with NTM-positive respiratory samples detected in two university hospitals of the French overseas department of Reunion Island. We recorded the prevalence of M. simiae in this cohort, as well as the clinical, radiological, and microbiological features of patients with at least 1 sample positive for M. simiae In our cohort, 97 patients (15.1%) were positive for M. simiae Twenty-one patients (21.6%) met the American Thoracic Society (ATS) criteria for infection. M. simiae infection was associated with bronchiectasis, micronodular lesions, and weight loss. Antibiotic susceptibility testing was performed for 60 patients, and the isolates were found to have low susceptibility to antibiotics, except for amikacin, fluoroquinolones, and clarithromycin. Treatment failed for 4 of the 8 patients treated for M. simiae infection. Here, we describe a specific cluster corresponding to a large cohort of patients with M. simiae, a rare nontuberculous mycobacterium associated with low pathogenicity and poor susceptibility to antibiotics.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  Mycobacterium simiae; lung; nontuberculous mycobacteria; respiratory

Mesh:

Substances:

Year:  2018        PMID: 29760130      PMCID: PMC6021628          DOI: 10.1128/AAC.00395-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

Review 1.  Disseminated Mycobacterium simiae infection in patients with AIDS.

Authors:  H M Al-Abdely; S G Revankar; J R Graybill
Journal:  J Infect       Date:  2000-09       Impact factor: 6.072

2.  Mycobacterium simiae Infection in an Immunocompromised Patient without Acquired Immunodeficiency Syndrome.

Authors:  Beatriz Braun-Saro; Jaime Esteban; Soledad Jiménez; Jose M Castrillo; Manuel L Fernández-Guerrero
Journal:  Clin Infect Dis       Date:  2002-01-24       Impact factor: 9.079

3.  Environmental risks for nontuberculous mycobacteria. Individual exposures and climatic factors in the cystic fibrosis population.

Authors:  D Rebecca Prevots; Jennifer Adjemian; Aisling G Fernandez; Michael R Knowles; Kenneth N Olivier
Journal:  Ann Am Thorac Soc       Date:  2014-09

4.  Mycobacterium simiae infection in a patient with acquired immunodeficiency syndrome.

Authors:  J L Sampaio; N Artiles; R M Pereira; J R Souza; J P Leite
Journal:  Braz J Infect Dis       Date:  2003-02-21       Impact factor: 1.949

5.  Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients.

Authors:  M Dailloux; M L Abalain; C Laurain; L Lebrun; C Loos-Ayav; A Lozniewski; J Maugein
Journal:  Eur Respir J       Date:  2006-12       Impact factor: 16.671

6.  Clinical and microbiological assessment of Mycobacterium simiae isolates from a single laboratory in southern Arizona.

Authors:  D L Rynkiewicz; G D Cage; W R Butler; N M Ampel
Journal:  Clin Infect Dis       Date:  1998-03       Impact factor: 9.079

7.  Clinical relevance of Mycobacterium simiae in pulmonary samples.

Authors:  J van Ingen; M J Boeree; P N R Dekhuijzen; D van Soolingen
Journal:  Eur Respir J       Date:  2008-01       Impact factor: 16.671

8.  Clinical and radiological features of Mycobacterium kansasii infection and Mycobacterium simiae infection.

Authors:  David Shitrit; Nir Peled; Jihad Bishara; Rachel Priess; Silvio Pitlik; Zmira Samra; Mordechai R Kramer
Journal:  Respir Med       Date:  2008-07-10       Impact factor: 3.415

9.  Clinical isolates of Mycobacterium simiae in San Antonio, Texas. An 11-yr review.

Authors:  G Valero; J Peters; J H Jorgensen; J R Graybill
Journal:  Am J Respir Crit Care Med       Date:  1995-11       Impact factor: 21.405

10.  Computed Tomography Findings of Pulmonary Mycobacterium simiae Infection.

Authors:  Ayeh Baghizadeh; Payam Mehrian; Poopak Farnia
Journal:  Can Respir J       Date:  2017-01-03       Impact factor: 2.409

View more
  7 in total

1.  Growing Knowledge about Mycobacterium simiae from Two Recent Studies.

Authors:  Amal Hamieh; Ralph Tayyar; Souha Kanj
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

2.  Mycobacterium simiae: Harmless colonizer or deadly pathogen?

Authors:  Jean-Francois Jabbour; Amal Hamieh; Sima L Sharara; Souha S Kanj
Journal:  PLoS Pathog       Date:  2020-04-30       Impact factor: 6.823

3.  A case of multidrug-resistant Mycobacterium simiae in an elderly woman.

Authors:  Hadi Lotfi; Ehsan Aryan; Mojtaba Sankian; Zahra Meshkat; Ahmad Khalifeh Soltani; Amir Hooshang Alvandi; Hadi Farsiani
Journal:  Respirol Case Rep       Date:  2021-02-01

Review 4.  Role of Williamsia and Segniliparus in human infections with the approach taxonomy, cultivation, and identification methods.

Authors:  Mehdi Fatahi-Bafghi
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-01-23       Impact factor: 3.944

5.  Epidemiology of infection by pulmonary non-tuberculous mycobacteria in French Guiana 2008-2018.

Authors:  Milène Chaptal; Claire Andrejak; Timothée Bonifay; Emmanuel Beillard; Geneviève Guillot; Stéphanie Guyomard-Rabenirina; Magalie Demar; Sabine Trombert-Paolantoni; Veronique Jacomo; Emilie Mosnier; Nicolas Veziris; Felix Djossou; Loïc Epelboin
Journal:  PLoS Negl Trop Dis       Date:  2022-09-09

6.  Drug susceptibility profiling and genetic determinants of drug resistance in Mycobacterium simiae isolates obtained from regional tuberculosis reference laboratories of Iran.

Authors:  Sara Daneshfar; Azar Dokht Khosravi; Mohammad Hashemzadeh
Journal:  PLoS One       Date:  2022-08-12       Impact factor: 3.752

7.  Mycobacterium simiae pulmonary disease in Iran: systematic review and meta-analysis.

Authors:  M J Nasiri; M Heidary; T Azimi; H Goudarzi; P Tabarsi; D D Sarokhalil; M M Feizabadi
Journal:  New Microbes New Infect       Date:  2018-09-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.